Hot Features
プレミアム
LeonaBio Inc (LONA)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | 17.10k | 0.00 | Derivative Exercise and Retained Stock | - | 59.89k | 39.95% |
| 2026-03-03 | Dr. Mark J. LittonPresident, CEO & Director | -5.16k | 27.69k | Derivative Exercise and Sale | 5.37 | 59.89k | - |
| 2026-03-03 | Mr. Robert RenningerCFO | 2.99k | 0.00 | Derivative Exercise and Retained Stock | - | 15.85k | 23.29% |
| 2026-03-03 | Mr. Robert RenningerCFO | -906.00 | 4.87k | Derivative Exercise and Sale | 5.37 | 15.85k | - |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 4.40k | 0.00 | Derivative Exercise and Retained Stock | - | 18.38k | 31.46% |
| 2026-03-03 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -1.33k | 7.13k | Derivative Exercise and Sale | 5.37 | 18.38k | - |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | 4.50k | 0.00 | Derivative Exercise and Retained Stock | - | 25.18k | 21.74% |
| 2026-03-03 | Dr. Kevin ChurchChief Scientific Officer | -1.36k | 7.30k | Derivative Exercise and Sale | 5.37 | 25.18k | - |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | 5.70k | 0.00 | Derivative Exercise and Retained Stock | - | 15.89k | 55.92% |
| 2026-03-03 | Dr. Javier San MartinChief Medical Officer | -1.72k | 9.24k | Derivative Exercise and Sale | 5.37 | 15.89k | - |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | 3.02k | 0.00 | Derivative Exercise and Retained Stock | - | 10.19k | 42.19% |
| 2025-12-31 | Dr. Javier San MartinChief Medical Officer | -1.64k | 11.31k | Derivative Exercise and Sale | 6.88 | 10.19k | - |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | 8.25k | 0.00 | Derivative Exercise and Retained Stock | - | 42.80k | 23.87% |
| 2025-12-31 | Dr. Mark J. LittonPresident, CEO & Director | -2.59k | 17.79k | Derivative Exercise and Sale | 6.88 | 42.80k | - |
| 2025-12-31 | Mr. Robert RenningerCFO | 939.00 | 0.00 | Derivative Exercise and Retained Stock | - | 12.86k | 7.88% |
| 2025-12-31 | Mr. Robert RenningerCFO | -297.00 | 2.04k | Derivative Exercise and Sale | 6.88 | 12.86k | - |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | 2.79k | 0.00 | Derivative Exercise and Retained Stock | - | 20.68k | 15.60% |
| 2025-12-31 | Dr. Kevin ChurchChief Scientific Officer | -876.00 | 6.03k | Derivative Exercise and Sale | 6.88 | 20.68k | - |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2.79k | 0.00 | Derivative Exercise and Retained Stock | - | 13.98k | 24.95% |
| 2025-12-31 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -876.00 | 6.03k | Derivative Exercise and Sale | 6.88 | 13.98k | - |
| 2025-12-18 | Perceptive Advisors LLC法人 | 1.32M | 8.38M | 買い | 6.35 | 1.86M | 244.13% |
| 2025-06-30 | Dr. Kevin ChurchChief Scientific Officer | 2.81k | 0.00 | Derivative Exercise and Retained Stock | - | 16.89k | 19.99% |
| 2025-06-30 | Dr. Kevin ChurchChief Scientific Officer | -852.60 | 2.50k | Derivative Exercise and Sale | 2.94 | 16.89k | - |
| 2025-06-30 | Dr. Mark J. LittonPresident, CEO & Director | 8.32k | 0.00 | Derivative Exercise and Retained Stock | - | 34.55k | 31.73% |
| 2025-06-30 | Dr. Mark J. LittonPresident, CEO & Director | -2.51k | 7.37k | Derivative Exercise and Sale | 2.94 | 34.55k | - |
| 2025-06-30 | Dr. Javier San MartinChief Medical Officer | 3.58k | 0.00 | Derivative Exercise and Retained Stock | - | 7.17k | 99.94% |
| 2025-06-30 | Dr. Javier San MartinChief Medical Officer | -1.08k | 3.18k | Derivative Exercise and Sale | 2.94 | 7.17k | - |
| 2025-06-30 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | 2.81k | 0.00 | Derivative Exercise and Retained Stock | - | 11.19k | 33.60% |
| 2025-06-30 | Mr. Mark F. WorthingtonGeneral Counsel, CCO & Corporate Secretary | -852.60 | 2.50k | Derivative Exercise and Sale | 2.94 | 11.19k | - |
| 2025-06-30 | Mr. Robert RenningerCFO | 946.20 | 0.00 | Derivative Exercise and Retained Stock | - | 10.92k | 9.49% |
| 2025-06-30 | Mr. Robert RenningerCFO | -289.70 | 850.27 | Derivative Exercise and Sale | 2.94 | 10.92k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
